摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

环辛醇 | 3637-63-6

中文名称
环辛醇
中文别名
环辛烷甲醇
英文名称
cyclooctylmethanol
英文别名
cyclooctanemethanol;Hydroxymethyl-cyclooctan
环辛醇化学式
CAS
3637-63-6
化学式
C9H18O
mdl
——
分子量
142.241
InChiKey
ZHPBLHYKDKSZCQ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    126 °C (22 mmHg)
  • 密度:
    0.94
  • 闪点:
    93 °C
  • 稳定性/保质期:

    在常温常压下,该物质保持稳定。

计算性质

  • 辛醇/水分配系数(LogP):
    3
  • 重原子数:
    10
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    20.2
  • 氢给体数:
    1
  • 氢受体数:
    1

安全信息

  • 海关编码:
    2906199090
  • 储存条件:
    请将药品存放在避光、通风干燥的地方,并密封保存。

SDS

SDS:4f402f6e9681406a824d389ea8f365c8
查看
Name: Cyclooctanemethanol Material Safety Data Sheet
Synonym: None Known
CAS: 3637-63-6
Section 1 - Chemical Product MSDS Name:Cyclooctanemethanol Material Safety Data Sheet
Synonym:None Known

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
CAS# Chemical Name content EINECS#
3637-63-6 Cyclooctanemethanol ca. 100 222-862-9
Hazard Symbols: None Listed.
Risk Phrases: None Listed.

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
The toxicological properties of this material have not been fully investigated.
Potential Health Effects
Eye:
May cause eye irritation. May cause chemical conjunctivitis and corneal damage.
Skin:
May cause skin irritation. May cause cyanosis of the extremities.
Ingestion:
May cause gastrointestinal irritation with nausea, vomiting and diarrhea. The toxicological properties of this substance have not been fully investigated.
Inhalation:
May cause respiratory tract irritation. The toxicological properties of this substance have not been fully investigated. Aspiration may lead to pulmonary edema. Inhalation at high concentrations may cause CNS depression and asphixiation.
Chronic:
Effects may be delayed.

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid. Do NOT use mouth-to-mouth resuscitation.
Notes to Physician:
Treat symptomatically and supportively.

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion. Will burn if involved in a fire. Combustible liquid. Vapors may be heavier than air. They can spread along the ground and collect in low or confined areas. Containers may explode when heated. Runoff from fire control or dilution water may cause pollution.
Extinguishing Media:
Use water spray to cool fire-exposed containers. Use water spray, dry chemical, carbon dioxide, or chemical foam.

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth), then place in suitable container. Avoid runoff into storm sewers and ditches which lead to waterways. Clean up spills immediately, observing precautions in the Protective Equipment section. Remove all sources of ignition. Use a spark-proof tool. Provide ventilation.

Section 7 - HANDLING and STORAGE
Handling:
Wash thoroughly after handling. Use only in a well-ventilated area.
Avoid breathing dust, vapor, mist, or gas. Avoid contact with eyes, skin, and clothing. Empty containers retain product residue, (liquid and/or vapor), and can be dangerous. Keep container tightly closed.
Keep away from heat, sparks and flame. Avoid ingestion and inhalation. Do not pressurize, cut, weld, braze, solder, drill, grind, or expose empty containers to heat, sparks or open flames.
Storage:
Keep away from sources of ignition. Store in a cool, dry place.
Store in a tightly closed container.

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 3637-63-6: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Liquid
Color: colorless
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: 126 deg C @ 22 mmHg
Freezing/Melting Point: Not available.
Autoignition Temperature: Not available.
Flash Point: 93 deg C ( 199.40 deg F)
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density: 0.94
Molecular Formula: C9H18O
Molecular Weight: 142.24

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatible materials, ignition sources, excess heat.
Incompatibilities with Other Materials:
Oxidizing agents Hazardous Decomposition Products:
Carbon monoxide, carbon dioxide.
Hazardous Polymerization: Has not been reported

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 3637-63-6 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
Cyclooctanemethanol - Not listed by ACGIH, IARC, or NTP.

Section 12 - ECOLOGICAL INFORMATION


Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

Section 14 - TRANSPORT INFORMATION

IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
WGK (Water Danger/Protection)
CAS# 3637-63-6: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 3637-63-6 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 3637-63-6 is not listed on the TSCA inventory.
It is for research and development use only.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    环辛醇铬酸 作用下, 生成 辛二酸
    参考文献:
    名称:
    Ruzicka; Brugger, Helvetica Chimica Acta, 1926, vol. 9, p. 403
    摘要:
    DOI:
  • 作为产物:
    描述:
    环辛酮正丁基锂硼烷四氢呋喃络合物 作用下, 以 四氢呋喃正己烷 为溶剂, 反应 0.67h, 生成 环辛醇
    参考文献:
    名称:
    铈光催化使醇脱羟甲基化
    摘要:
    脱羟甲基化是将醇原料直接转化为少一个碳原子的烷基合成子,是一种利用醇材料的普遍性和稳健性的非常规且未充分探索的策略。在温和且氧化还原中性的反应条件下,利用廉价的铈催化剂,提供了光催化脱羟甲基化平台。通过配体到金属的电荷转移催化,醇官能团已可靠地转移到亲核自由基中,同时失去一分子甲醛。有趣的是,我们发现铈催化剂可以显着促进脱羟甲基化过程,并且碎片自由基的稳定作用也起着重要作用。这种操作简单的方案能够直接利用伯醇作为非常规烷基亲核试剂,用于自由基介导的 1,4-共轭加成与迈克尔受体。广泛的醇类,从简单的乙醇到复杂的核苷和类固醇,已成功应用于这种片段偶联转化。此外,该催化系统的模块化已在多种自由基介导的转化中得到证实,包括氢化、胺化、烯基化和氧化。
    DOI:
    10.1021/jacs.9b05932
点击查看最新优质反应信息

文献信息

  • [EN] NEW BIARYL AMIDE DERIVATIVES<br/>[FR] NOUVEAUX DÉRIVÉS DE BIARYLAMIDE
    申请人:HOFFMANN LA ROCHE
    公开号:WO2012089601A1
    公开(公告)日:2012-07-05
    The invention provides novel compounds having the general formula (I) wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11, R12 and A are as described herein, compositions including the compounds and methods of using the compounds.
    这项发明提供了具有通式(I)的新化合物,其中R1、R2、R3、R4、R5、R6、R7、R8、R9、R10、R11、R12和A如本文所述,包括这些化合物的组合物以及使用这些化合物的方法。
  • [EN] NEW ARYL-QUINOLINE DERIVATIVES<br/>[FR] NOUVEAUX DÉRIVÉS D'ARYLQUINOLÉINE
    申请人:HOFFMANN LA ROCHE
    公开号:WO2013064465A1
    公开(公告)日:2013-05-10
    The invention provides novel compounds having the general formula (I), wherein R1, R2, R3, R4 R5, R6 and n are as described herein, compositions including the compounds and methods of using the compounds.
    本发明提供了具有通用公式(I)的新颖化合物,其中R1、R2、R3、R4、R5、R6和n如本文所述,包括这些化合物的组合物以及使用这些化合物的方法。
  • Inhibitors of c-Jun N-terminal kinases
    申请人:Liu Gang
    公开号:US20060173050A1
    公开(公告)日:2006-08-03
    The present invention relates to compounds that are inhibitors of c-jun N-terminal kinase 1, 2, or 3 (JNK1, JNK2, or JNK3), compositions containing the compounds and the use of the compounds in the prevention or treatment of disorders regulated by the activation of JNK1, JNK2 and JNK3.
    本发明涉及作为c-jun N-末端激酶1、2或3(JNK1、JNK2或JNK3)抑制剂的化合物,包含这些化合物的组合物以及这些化合物在预防或治疗由JNK1、JNK2和JNK3激活调控的疾病中的用途。
  • NEW BIARYL AMIDE DERIVATIVES
    申请人:Aebi Johannes
    公开号:US20120165338A1
    公开(公告)日:2012-06-28
    The invention provides novel compounds having the general formula (I) wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , R 10 , R 11 , R 12 and A are as described herein, compositions including the compounds and methods of using the compounds.
    这项发明提供了具有一般式(I)的新化合物,其中R1、R2、R3、R4、R5、R6、R7、R8、R9、R10、R11、R12和A如本文所述,包括这些化合物的组合物以及使用这些化合物的方法。
  • [EN] NEW OCTAHYDRO-CYCLOBUTA [1,2-c;3,4-c']DIPYRROL-2-YL<br/>[FR] NOUVEL OCTAHYDRO-CYCLOBUTA [1,2-C; 3,4-C'] DIPYRROL-2-YL
    申请人:HOFFMANN LA ROCHE
    公开号:WO2015078803A1
    公开(公告)日:2015-06-04
    The invention provides novel compounds having the general formula (I) wherein R1, Y and R2 are as described herein, compositions including the compounds and methods of using the compounds.
    这项发明提供了具有一般式(I)的新化合物,其中R1、Y和R2如本文所述,包括这些化合物的组合物和使用这些化合物的方法。
查看更多

表征谱图

  • 氢谱
    1HNMR
  • 质谱
    MS
  • 碳谱
    13CNMR
  • 红外
    IR
  • 拉曼
    Raman
查看更多图谱数据,请前往“摩熵化学”平台
mass
查看更多图谱数据,请前往“摩熵化学”平台
ir
raman
  • 峰位数据
  • 峰位匹配
  • 表征信息
Shift(ppm)
Intensity
查看更多图谱数据,请前往“摩熵化学”平台
Assign
Shift(ppm)
查看更多图谱数据,请前往“摩熵化学”平台
测试频率
样品用量
溶剂
溶剂用量
查看更多图谱数据,请前往“摩熵化学”平台